A patient with a genetic mutation has decreased Factor XIII production. If this patient sustains a deep wound, which coagulation outcome is most likely?

💡 Explanation

Decreased Factor XIII leads to unstable clot formation because Factor XIII is responsible for cross-linking fibrin monomers within the blood clot. Therefore, the clot forms initially, but fibrin cross-linking is impaired, leading to premature clot lysis, rather than stable clot formation.

• If a drug exhibits significant first-pass metabolism following oral administration, which consequence follows, necessitating a higher dose compared to intravenous administration?
• What happens to thyrotropin-releasing hormone (TRH) secretion when exogenous thyroid hormone (T4) is administered, mimicking hyperthyroidism?
• Why does cancer treatment that targets growth factor receptors sometimes fail to induce apoptosis in tumor cells despite initial inhibition of cell division?
• If a patient exhibits prolonged bleeding times despite normal platelet count after taking a new medication, which mechanism of platelet aggregation is most likely inhibited?
• Why does a patient with advanced cirrhosis often experience decreased blood pressure despite increased cardiac output?
• Why does polyspermy generally fail to produce viable human embryos after in vitro fertilization?